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Abstract
Introduction—Birth weight often is used to predict how preterm infants will grow, but scant
attention has been paid to the effect of neonatal morbidities on growth trajectories. We investigated
birth weight and neonatal morbidity in preterm infants' growth to age 12 years.
Method—A five-group, prospective, longitudinal study was conducted with 194 infants: 46 full
term; 29 healthy preterm without morbidity; 56 preterm with medical illness (MPT); 34 preterm with
neurologic illness; and 29 preterm small for gestational age (SGA). Height, weight, and body mass
index were measured at six ages.
Results—The full-term group had greater height than the preterm groups to age 8 years, when
healthy preterm and MPT groups caught up. Only the SGA group had smaller height at age 12 years.
The MPT, preterm with neurologic illness, and SGA groups had lower weight through age 12 years.
Body mass index was appropriate for preterm groups by age 4 years. Across time, neonatal morbidity
had a significant effect on height and weight trajectories. Birth weight was significant for weight
trajectories only.
Discussion—With variation in growth trajectories, details of neonatal morbidity in health history
interviews will inform child health assessments.
Wide-ranging differences in growth exist between full-term (FT) children born with normal
birth weight and those born prematurely. With the exception of infants with severe impairment,
infants weighing less than 1500 g are likely to remain smaller. There is evidence of “catch-up”
growth for preterm children at school age (6–9 years) when growth is comparable with their
normal birth weight peers (Albertsson-Wiklund & Karlberg, 1994; Hack, Weissman, &
Borawski-Clark, 1996). Infants born at weights categorized as very low birth weight (VLBW;
1000–1499 g) and extremely low birth weight (ELBW; < 1000 g) remain smaller than their
normal birth weight peers at adolescence (Ford, Doyle, Davis, & Callanan, 2000; Peralta-
Carcelen et al., 2000; Powls, Botting, Cooke, Pilling, & Marlow, 1996; Saigal, Stoskopf,
Striener, & Burrows, 2001). Factors predicting or correlating with growth attainment in preterm
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children include birth weight, small for gestational age (SGA) status (Ford et al.; Powls et al.;
Saigal et al.), neurologic impairment and neonatal illnesses, parental height (Albertsson-
Wiklund & Karlberg, 1994; Powls et al.; Saigal et al.), and social class (Vrlenich et al.,
1995). As for sex, Hack et al. (2003) speculated that the higher incidence of neonatal
complications in males may be one factor explaining why they showed less growth than females
at age 20 years.
The combination of one or more neonatal morbidities and a long neonatal intensive care unit
(NICU) course creates complex physiological stress to an immature system. Preterm infants
display autonomic and regulatory behaviors indicative of stress, and some intervention studies
in which NICU environmental stressors were reduced have shown improved weight gain
(Ferber et al., 2002). However, little or merely secondary consideration has been given to the
role of neonatal complications in growth trajectories, particularly beyond early school age.
In this study, we examined the longitudinal effect of neonatal morbidity on preterm growth
from birth to age 12 years. We have investigated two issues. The first is whether growth (i.e.,
height, weight, and body mass index [BMI]) was different for prematurely born infants
compared with FT healthy children. These preterm infants comprise four different neonatal
morbidity groups. The second issue we examined was whether birth weight modifies the effects
of these neonatal morbidity exposures. This is a five-group prospective design in which height,
weight, and BMI were measured at six time points: birth, 18 months, 30 months, 4 years, 8
years, and 12 years. Understanding the individual and combined influence of neonatal
morbidity and birth weight on preterm growth over time may explain why some preterm
children remain smaller than their full-term peers and inform pediatric professionals who
counsel parents of preterm infants.
Methods
Sample
This was a prospective, longitudinal study of 194 infants. For recruitment, potential preterm
infants were identified from a medical chart screening during the mother's postpartum stay or
during the infant's NICU stay. The FT infants were identified during the postpartum period
and in the same time frame (1985–1989) as the preterm infants. The criteria for recruitment
were neonatal diagnoses, birth weight less than 1850 g, maternal mental health (no history of
mental illness), and English as a primary language. Parent(s) then were invited to participate
by research nurses. Fewer than 10% of the parent(s) declined participation. Institutional Review
Board approval was obtained from both the hospital and university at each study time point.
Parents gave informed consent each time, while children signed assent at ages 8 and 12 years.
Five study groups were determined by neonatal morbidity status: a group of healthy FT infants
recruited from the hospital nursery with uncomplicated pregnancy, labor, and delivery; a group
of healthy preterm infants (HPT) without medical or neurologic illness; a group of medical
preterm infants (MPT) with clinical illness but without neurologic abnormality (e.g.,
bronchopulmonary dysplasia [BPD], respiratory distress syndrome [RDS], necrotizing
enterocolitis [NEC], sepsis); a group of neurologic preterm infants (NPT) with severe
neurologic illness (e.g., meningitis, hydrocephalus, grade 3 or 4 intraventricular hemorrhage
[IVH]); and a group of SGA preterm infants with or without medical problems. SGA was
defined as less than 10th percentile weight for gestational age (Lubchenco, Hansman, & Boyd,
1966). BPD was defined as oxygen requirement at 28 days of life. RDS required diagnosis
within the first 2 days, based on typical signs (grunting and retractions) and characteristic chest
radiograph findings. NEC was classified using Bell's criteria (Bell et al., 1978). Sepsis was
defined as high clinical suspicion when antepartum antibiotics had been administered plus all
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culture positive episodes. IVH was classified according to the highest Papile grade (Papile,
Burstein, Burstein, & Koffler, 1978).
Understanding the individual and combined influence of neonatal morbidity and birth
weight on preterm growth over time may explain why some preterm children remain
smaller than their full-term peers and inform pediatric professionals who counsel
parents of preterm infants.
Socioeconomic status (SES) was estimated so that there were approximately equal numbers
of high, middle, and low status infants in each of the five study groups. The infants, both FT
and preterm, received the standard of care at the time.
Measurement
Infant birth measures and neonatal illness were recorded from medical charts. Infant risk was
measured by the Hobel neonatal scale (Hobel, Hyvarien, Okada, & Oh, 1973), which evaluates
the presence of neonatal illness related to the systems of the body (i.e., respiratory, circulatory,
hematologic, and metabolic). Each item is given a weighted score with the resulting total score
representing the total risk for the infant, with higher scores indicating higher risk. Two NICU
advanced practice nurses extracted the neonatal data and calculated the Hobel score, and they
maintained an interrater reliability agreement of 97%.
Height and weight measurements were converted to sex- and age-specific percentiles and z
scores using the ANTHRO (Sullivan & Gorstein, 1999) anthropometry software program,
based on the Centers for Disease Control and Prevention (CDC) National Center for Health
Statistics growth data in Atlanta, Ga. BMI also was calculated with the ANTHRO program.
Babson and Benda (1976) percentiles for gestational age were used for the preterm infants at
birth. BMI (wt/ht2), calculated from weight and height measurements, is used to judge whether
weight is appropriate for height. The National Association of Pediatric Nurse Practitioners
(NAPNAP), the American Academy of Pediatrics, and the American Academy of Family
Physicians endorse universal screening using BMI and the use of BMI growth curves to identify
obese and overweight children (Moyer et al., 2005; NAPNAP, 2006).
Growth Assessment
In addition to recruitment and assessment at birth, children were seen at 18 months, 30 months,
4 years, 8 years, and 12 years as part of a research follow-up study of prematurity on
developmental outcomes. We corrected for gestational age up to 30 months. A health history
and physical assessment including growth measures were performed by nurses blinded to group
status. For height, infant length was measured using a paper tape, and when the child could
stand, a staidiometer attached to the wall was used with the child in stocking feet. For weight,
we used a balanced scale measured to the ¼ pound. After infancy, children were weighed while
wearing minimal clothing. The measurement was written in the chart in pounds and inches,
and later converted using ANTHRO. Pubertal development at age 12 years was determined by
the child's self-assessment of Tanner's standard photographs (Tanner, 1962). This self-
assessment was validated during health interviews with the parent(s). Adolescent assessment
is accurate and has excellent concordance with professionals (Duke, Litt, & Gross, 1980).
Parent height was self-reported.
Analytic Strategy
We used z scores in the longitudinal analysis because they are a more precise assessment of
growth than percentile cut-offs and better quantify growth at the extremes of the distribution
(Kuczmarski et al., 2002). They are preferable for statistical comparisons over time with fewer
violations of the underlying assumptions than would occur if percentiles were compared by
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parametric statistics. A z score of 0 equals the median (50th percentile), and a score of ±2
standard deviations (SDs) approximates the 98th and 2nd percentile, respectively.
Analysis of variance (ANOVA) was used to verify the a priori neonatal morbidity group
classification for the neonatal variables at the first time point. Height, weight, and BMI
percentiles z scores with 95% confidence intervals (CIs) were calculated for each time point.
We tested whether height and weight were significantly different between boys and girls at
each time point. Only at birth did the girls (M =−2.9 z score; SD = 2.1) have a higher weight
than boys (M = −3.7 z score; SD = 2.2). With only one difference, the sexes were combined to
increase statistical power for the trajectory analysis. BMI was calculated for boys and girls
from age 30 months because reference values are not established for children younger than 2
years. We examined the number of children who were below the third percentile as a gauge of
poor growth.
To answer the first aim of whether growth was different for the preterm groups compared with
the FT group, a mixed effects linear model was used to model the nonindependence of
observations within subjects over time using an unstructured covariance matrix (Bryk &
Raudenbush, 1992; Short et al., 2003). With this method, we modeled height and weight as a
function of neonatal morbidity group, age, linear and quadratic parameters for age (to detect
nonlinear trajectories), and the interactions between neonatal morbidity and the age terms using
SAS version 8.2 for UNIX (SAS Institute, Cary, NC). Successive model testing with interaction
terms were tested, but were only used if significant (at the 0.05 level). These interactions
determine if growth over time differs between the FT and preterm neonatal morbidity groups.
Univariate analysis with ANOVA followed the significant models. Next, birth weight, using
birth weight groups of ELBW (<1000 g); VLBW (<1000 g and <1500 g); low birth weight
(LBW, <1500 g and <2500 g); and FT (>2500 g) was added to the models to answer the second
aim of whether birth weight modified the effects of the neonatal morbidity exposures.
RESULTS
Neonatal Morbidity Groups
Five groups were enrolled as follows: 46 healthy FT infants, 29 HPT infants, 56 MPT infants,
34 NPT infants, and 29 SGA preterm infants. Table 1 illustrates the coherence of the a priori
criteria with the final sample characteristics. The range of Hobel neonatal risk scores (0–160)
included all levels of risk from none to very high. The sample was 88% White, 7% Hispanic,
5% Black, and 50% male. Mean maternal age was 27 years (SD = 6), with most completing
high school (M = 13 years; SD = 1.8) and 79% (n = 136) married or living with their partners.
SES (Hollingshead, 1975) was not different between groups over the six time points. Parental
height was not significantly different across study groups (Table 1).
There was variability in the sample size over the six time points, though our retention rates
were high, ranging from 88% to 97%. Follow-up rates at age 12 years were 93% for the FT
group, 100% for the HPT group, 91% for the MPT group, 91% for the NPT group, and 93%
for the SGA group. Maternal height, paternal height, and infant intake of kilo-calories per
kilogram per day (kcal/kg/day) at hospital discharge were not significantly different across
groups. There were no significant differences for pubertal stage across neonatal morbidity
groups (boys: X2 [32] = 39.37, P = .17; girls: X2 [36] = 33.8, P = .57). Sixty percent (n = 51)
of the boys and 50% (n = 48) of the girls were Tanner stage 0, while only 1.6% of the boys
(n = 2) and 1% of the girls (n = 1) were Tanner stage 5, thus illustrating early pubertal
development of the sample at age 12 years.
Ten children had a diagnosis of cerebral palsy and/or developmental disability, and their growth
was impaired. Some children had oral motor difficulties that may have inhibited adequate
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nutrition. We measured children who were wheelchair bound when we could or used the
pediatrician's weight and height or maternal report. In the analysis, we have included and
excluded these children, with no difference in the results. The results are presented for the full
sample.
Height, Weight and BMI of the FT Group
The mean height and weight z scores of the FT group remain near 0 or the 50th percentile from
birth to age 12 years, while the 95% confidence intervals were within .50 z score (SD = .5)
until ages 8 and 12 years. The 95% CI for the sample for height were: birth, .43 to –.20 18
months, –51 to .56; 30 months, −.07 to .71; 4 years, −.62 to .56; 8 years, −.44 to .45; and 12
years, −.41 to .40. The 95% confidence intervals for weight were: birth, .68 to .11; 18 months,
−.52 to .37; 30 months, −.53 to .23; 4 years, −.21 to .50; 8 years, −.01 to .76; and 12 years, .25
to 1.04 (Figures 1 and 2). The BMI mean scores for the FT boys and girls were within the
expected norms for age and sex with higher mean BMI at ages 8 and 12 years (Table 2). No
child was below the third percentile at ages 8 and 12 years. For the boys, the 95% CI range
widened from 1 point at the younger ages to 2 points at ages 4 and 8 years and 4 points at age
12 years. The range of the 95% CI for the girls was slightly less than 2 points at birth and 30
months, and then widened to 2.7 and 3.9 points at ages 8 and 12 years.
Height of the Healthy, Medical, Neurologic, and SGA Preterm Groups
For all the preterm groups, there were sharp increases in height between birth and 18 months
(see Figure 1). In the HPT group (Figure 1A), the mean height z score fell slightly from 18
months to 4 years, then increases steadily to age 12 years. The upper 95% CI reaches 0 z score
at 18 months (95% CI: .18 to −1.15), 30 months (95% CI: −.01 to −1.24), and age 4 years (95%
CI: −.04 to −1.1). Although the mean values were lower, the MPT group (Figure 1B) followed
the height trajectory pattern of the FT group, which slightly increased at 30 months (95% CI:
0.2 to −0.6), then slightly decreased until age 4 years (95% CI: −.25 to −.94), remained steady
at −.5 z score (95% CI: −.22 to −.83) at age 8 years, then rose to −.19 z score at 12 years (95%
CI: .12 to −.47). The width of the 95% CI was narrower than the HPT group, with the upper
95% CI limit near 0 z score from age 18 months. The NPT group (Figure 1C) had the shortest
mean length z score of all groups at birth (−5.67, 95% CI: −5.15 to −6.19), the mean height z
score increased to −.08 (95% CI: .61 to −.78) at 30 months, fell to −.58 (95% CI: −.22 to −1.47)
at age 4 years, and −.65 (95% CI: −.15 to −1.15) at age 8 years, then rose to −.28 (95% CI: .
21 to −.77) at age 12 years. After the sharp rise from birth to 18 months, the SGA preterm
group mean z scores were the lowest of all preterm groups between 18 and 144 months,
remaining near −1.0 (Figure 1D). The range of the 95% CI varied from −.44 to −1.89 at 30
months, to −.64 to −1.36 at age 8 years, then widened again at age 12 years to −.29 to −1.6.
The upper 95% CI were no higher than 0 z score.
Weight of the Healthy, Medical, Neurologic, and SGA Preterm Groups
Weight gain for all the preterm groups sharply increased from birth to 18 months. For the HPT
group (Figure 2A), the mean weight z score rose to −.18 (95% CI: 0.6 to −0.97) at 18 months,
then decreased to −1.0 z score (95% CI: −0.42 to .1.5) at 30 months, then increased steadily to
age 12 years (mean = .78; 95% CI: −0.3 to 1.5) to surpass the FT group after age 8 years. A
wide range existed in the 95% CI across the time points. For the MPT group (Figure 2B), the
mean weight z score increased to −.97 (95% CI: −0.7 to −1.28) at 18 months, then steadily
increased across time, not reaching 0 z score until age 12 years (95% CI: .33 to −.33). The
upper 95% CI were below 0 z score until age 8 years (mean −.17, 95% CI: .14 to −0.48). The
NPT group (Figure 2C) had the lowest mean weight z score at birth of the preterm groups. The
mean weight increased to −.82 at 18 months (95% CI: −.36 to −1.43), fell to −1.02 (95% CI:
−.42 to −1.5) at 30 months, then returned nearing the 18-month mean (−.79; 95% CI: −.41 to
Sullivan et al. Page 5
J Pediatr Health Care. Author manuscript; available in PMC 2010 February 12.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
−1.24) at age 4 years, and continued to increase at ages 8 years (mean =−.52, 95% CI: −.08 to
−.96) and 12 years (mean = −.17, 95% CI: −.19 to −.68). The 95% CI range was approximately
1 z score, and the upper limit CI did not reach 0 z score until age 8 years. The SGA preterm
group (Figure 2D) mean weight z scores are the lowest of all preterm groups between 18 and
144 months. At 18 months the mean was −1.5 z score (95% CI: −1.1 to −1.97), and steadily
increased across time to −.08 (95% CI: .26 to −.63) at age 12 years.
BMI of the Healthy, Medical, Neurologic, and SGA Preterm Groups
The mean BMI for the boys in the preterm groups were slightly below the FT group and the
50th percentile at 30 months (Table 2). The HPT, NPT, and SGA preterm groups were 1.6
points below the 50th percentile for age, while the MPT group was less than 1 percentile point
(0.7). The mean differences below the 50th percentile were smaller by age 4 years, and fewer
children were below the third percentile by age 8 years. By age 12 years, the BMI mean
differences were above the 50th percentile, and only one boy in the HPT group and two boys
in the NPT group were below the third percentile.
In contrast, the girls in the pre-term groups had mean BMI scores close to the age-specific
mean at 30 months (Table 2). The MPT group had the lowest mean, while the NPT group had
the highest mean. The mean differences for the preterm groups were all less than 1 percentile
point. From age 4 years onward, the mean differences for the preterm groups were above the
50th percentile, and only 1 girl in each preterm group had a BMI score below the third
percentile.
Comparing Growth Trajectories between the FT and Preterm Groups
Neonatal morbidity group had a significant effect on height trajectory over time (X2 [20] =
225.7, P < .0001). The statistical interaction between neonatal morbidity and the quadratic
parameter term confirmed that the curvilinear trajectory of the neonatal morbidity groups
differs from the flat trajectory of the FT group. These trajectories are illustrated in Figures 1
and 2. The main effects of neonatal group and time were statistically significant. For this model,
the intercept was −4.8 z score. With the 1 unit addition of a FT group, height increased 4.9 z
score, thus illustrating the +0.1 z score mean of the reference population. The 1 unit addition
of the HPT group increased height 1.17 z score, which when added to the intercept, yields a
very low z score of −3.6. The 1 unit addition of the MPT group increased height z score .09,
and the 1 unit addition of the NPT group decreased height z score −.27. Thus, for the preterm
groups with medical or neurologic morbidity, there was reduced height. The negative sign for
the interaction term indicates that for the preterm groups with neonatal morbidity, the positive
effects of age (time) are reduced. The univariate analysis shows that the height z score for the
FT group had greater height than all the preterm groups until age 8 years, when the HPT group
and MPT group had caught up. At the age 12 years assessment, only the SGA group had lower
height compared with the other groups.
The neonatal morbidity group had a significant effect on weight trajectory over time (X2 [20]
= 356.45, P < .0001). The statistical interaction between neonatal morbidity and the quadratic
parameter term confirmed differences between the curvilinear trajectory of the neonatal
morbidity groups and the flat trajectory of the FT group. For this model, the intercept was −4.4
z score. With the 1 unit addition of an FT group, height increased 4.7 z score, thus illustrating
the +0.3 z score mean of the reference population. The 1 unit addition of the HPT group
increased weight .69 z score, which when added to the intercept, yields a very low z score of
−3.7. The 1 unit addition of the MPT group increased weight z score .06, and the 1 unit addition
of the NPT group decreased weight z score −.27. Similar to the height trajectory analysis, the
preterm groups with medical or neurologic morbidity had lower weight and the positive effects
of age (time). The univariate analysis shows that the weight z score for the FT group had greater
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weight than all the preterm groups until age 4 years, when the HPT group weight was not
different from the FT group. The significantly lower mean weight of the remaining three
neonatal groups (MPT, NPT, SGA) compared with the FT and HPT groups remained at ages
8 and 12 years.
Growth Trajectory Models with Birth Weight and Neonatal Morbidity
Birth weight was added to the models to examine whether birth weight modified the effects of
these neonatal morbidity exposures In the most parsimonious models, the main effect of birth
weight and neonatal morbidity group were statistically significant for height trajectories (X2
[20] = 348.48, P = .0001), but only birth weight was significant for weight trajectories (X2 [20]
= 473.81, P = .0001). The interaction between birth weight x neonatal morbidity was not
significant for either the height or weight models. Thus there was not a multiplicative effect
of neonatal morbidity and birth weight on height and weight trajectories through age 12 years.
For height, the intercept was −2.6, the 1 unit addition of the SGA group slope decreased height
−3.7 z score, which when added to the intercept, yields a low z score of −6.3. The 1 unit addition
of the HPT group slope decreased height −2.0 z score, the 1 unit addition of the MPT group
decreased height slope −3.5 z score, and the 1 unit addition of the NPT group decreased height
slope −3.3 z score. The point estimate for the addition of birth weight group was not significant.
For weight, the intercept was −2.6, the 1 unit addition of the SGA group decreased weight
slope −2.8 z score, which when added to the intercept, yields a low z score of −5.8. The 1 unit
addition of the HPT group decreased weight slope −2.7 z score, the 1 unit addition of the MPT
group decreased weight slope −2.9 z score, and the 1 unit addition of the NPT group decreased
weight slope −3.1 z score. The point estimate for the 1 unit addition of birth weight group
slightly increased weight slope .72 z score. Thus, the addition of birth weight with neonatal
morbidity, although statistically significant, had a relatively small effect on slopes for weight.
DISCUSSION
Our growth trajectory results show that neonatal morbidity exerts a continued effect on height
and weight from birth to age 12 years. The mixed effects linear models were significant for
the growth trajectories to age 12 years with a main effect of neonatal morbidity. The interactions
indicate that preterm height and weight growth trajectories differ from the FT group. When
plotting z score means uncorrected for prematurity, we see the expected rapid increment in
growth between birth and 18 months of age for all the preterm groups, followed by different
fluctuations. For height, the FT group had statistically higher height than did the preterm groups
to age 8 years, when the HPT and MPT groups caught up, so that at age 12 years only the SGA
group had smaller height. For weight, the catch-up trajectory was slower. The HPT group had
caught up by age 4 years, but the MPT, NPT, and SGA preterm groups continue to have lower
weight through age 12 years. The SGA group had the lowest weight and the smallest height,
reaching a group mean 34th percentile by age 12 years. The BMI growth from 30 months to
12 years shows appropriate weight for height for preterm boys and girls with or without
neonatal morbidity by age 4 years and very little evidence of being underweight. BMI has
received increased attention for pediatric use to screen for over-weight adolescents and
children, ages 2 years and older, and to characterize underweight (though no expert guidelines
exist for the classification of underweight based on BMI).
Our growth trajectory results show that neonatal morbidity exerts a continued effect
on height and weight from birth to age 12 years.
Hack and colleagues (2003; 1996) monitored 195 VLBW children born between 1977–1979
to ages 8 and 20 years and reported that boys had lower height, weight and BMI, while girls
had lower weight and BMI at age 8 years. These findings are in contrast to our data, where sex
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was not a significant factor differentiating growth trajectories to age 12 years. Only 10 children
had experienced severe sequelae, making growth assessment difficult. The trajectory models
remained significant when these children were removed from the models. Segmental measures
as a proxy for height may be a worthwhile when comparable growth charts are available
(Stevenson, 1995).
During the neonatal period, factors influencing growth include neonatal illness, birth weight,
poor sucking, appetite, long hospitalization, and difficulty with maternal-infant interaction. In
this study, infants were classified into neonatal morbidity groups at NICU discharge after the
birth growth measures were taken. An unstable neonatal course may disrupt physiologic and
regulatory systems, contributing to poorer feeding and subsequent growth. We know that
during the course of the study, none of the children were rehospitalized for failure to thrive,
had feeding tubes, or were malnourished according to our health history interview or
pediatrician records. For this sample, hospital discharge data show no neonatal morbidity group
differences in in-take of kilocalorie per kilogram per day. Our measurement of the intake of
calories at discharge was taken at a time when the infants were fairly healthy and should have
been similar across groups. Research approaches considering specific morbidities and calorie/
nutrient intake with regular growth measures may help us understand how much energy
expenditures are drained for NICU survival and physiologic equilibrium at the expense of early
growth.
There are consistent reports of SGA growth delay at ages 5 to 6 years from mid-1970s cohorts
(Hadders-Algra & Touwen, 1990). Hack et al. (1996) reported slower rates of catch-up for
VLBW SGA preterm children at age 8 years, with more SGA boys than girls with subnormal
weight and height. At age 14 years, Peralta-Carcelen and colleagues (2000) reported
significantly lower height and weight in ELBW. Neonatal morbidities of apnea, BPD, IVH,
sepsis, NEC, patent ductus arteriosis, and seizures were matched in the 1993 SGA versus
appropriate for gestational age comparison study by Sung, Vohr, and Oh (1993). These
children, born at the same time as our sample, had smaller height and weight at 1, 2, and 3
years of age, but head circumference did not differ by age 3 years.
Despite neonatal morbidity grouping, at age 12 years, most of the boys and girls in the sample
were in early stages of pubertal development. In the United States, the growth spurt
accompanying puberty occurs at 12.2 years for girls and 12.6 years for boys, so the majority
of the sample is still to experience this growth spurt and their adult height. Three reports from
preterm cohorts born between 1977 and 1984, earlier than the present sample, found no FT-
preterm differences in sexual maturity using the same measure, Tanner stages. Neither Peralta-
Carcelen and colleagues (2000), who compared adolescents born ELBW and NBW at age 14½
years, nor Ford et al. (2000), who compared ELBW, VLBW and NBW adolescents at age 14
years, nor Powls et al. (1996), who compared VLBW and NBW adolescents at age 12 years,
found pubertal development differences. Collectively, these results contradict reports of
preterm children born in the 1970s of early sexual maturity for children born prematurely
(Nelson, 1983).
The addition of birth weight to the models showed a main effect, not an interaction effect, of
neonatal morbidity for height and weight trajectories. Birth weight added only a small effect
to the models for weight trajectories. Powls et al. (1996) tested the effect of birth weight, birth
weight for gestational age, gestation, sex, cystic periventricular leukomalacia, IVH (grade 2
or above), and neonatal convulsions on age 12 years height and reported only 3% variance
accounted by one variable, birth weight for gestational age. Hack et al. (2003) found birth
weight z score and duration of neonatal hospitalization to be a significant predictor of 20-year
growth attainment. Follow-up studies have reported on cohorts born in the late 1970s and early
1980s (Ford, 2000; Hack et al., 2002; Hack et al., 1996; Peralta-Carcelen et al., 2000; Saigal,
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2001). Our sample was recruited at birth between 1985–1989 and grouped by neonatal
morbidity, with a wide range of preterm birth weight (640 to 1800 g) and a FT comparison
group. While it is assumed that there is greater neonatal morbidity with smaller birth weight,
children with larger birth weight also may have neonatal illness.
Some persons suggest that prematurity induces alterations in metabolism that may result in
later obesity, with higher adult risk for cardiovascular changes and adult onset diabetes (Law,
2001). In a recent systematic review, a z score change less than .67 between two different
childhood ages was considered rapid growth, and rapid growth was associated with later obesity
(Monteiro & Victora, 2005). Epidemiologic evidence from Britain and Finland shows this
combination is associated with increased risk for adult coronary artery disease in adulthood,
especially for males (Erikson, Forsen, Tuomelihto, Osmond, & Barker, 2001; Law). Reduced
growth has been shown to increase the risk of hypertension, diabetes, and high cholesterol,
suggesting the fetal origins hypothesis that cardiovascular disease may result from the infant's
response to undernutrition, which permanently changes body physiology and structure. It will
be important to prospectively follow these preterm cohorts into adulthood to further test this
hypothesis.
Hack et al. (2003) found that VLBW males remained shorter and weighed less at age 20 years.
Kitchen, Doyle, Ford, and Callanan (1992), who monitored 269 VLBW, ELBW, and NBW
children born in 1977–1982, reported that ELBW and VLBW children were shorter at 2, 5,
and 8 years of age and weighed less at ages 2 and 5 years than did the NBW comparison. Height
increments for ELBW and VLBW boys between 5 and 8 years were smaller than the increments
for girls, and the ELBW group had higher incidence of neonatal morbidity including seizures,
IVH, BPD, retinopathy of prematurity, and NEC. For neonatal morbidity variables, only birth
weight predicted age 8 year weights below the 10th percentile, while only maternal height
predicted age 8 year heights. In a follow-up study, only birth weight less than 1000 g and
parental height was associated with short stature (Doyle, Ford, Abadilla, Warne, & Callanan,
1993). At age 14 years, the VLBW group had later catch-up weight from age 8 years compared
with the NBW group; although still lighter (girls = 7.3 kg; boys = 8.3 kg), they remained shorter
by 4.5 cm for girls and 5.8 cm for boys (Doyle, 2000). Powls et al. (1996) reported a mean
VLBW height difference of 4.1 cm at age 12 years. We found larger differences compared
with the FT group for the SGA boys (6.4 cm), SGA girls (8.5 cm), MPT boys (5.8 cm), and
NPT boys (5.3 cm). Saigal (2001) also found catch-up growth between ages 8 and 12–16 years
of 154 ELBW and 125 term control subjects born between 1977–1982. At age 8 years, the
ELBW group was significantly smaller in height, weight, and head circumference, but with
improvement, girls had more gain than boys at adolescence.
We decided to use ANTHRO because of the large volume of data and its facility to calculate
percentiles and z scores. We recognize that the 1977–1978 growth charts are based on a
primarily White national sample. However, our sample was born between 1985 and 1989, is
representative of NICU admissions of this time, and is primarily White. Using z scores in the
mixed effects models to examine growth indicated that our FT group was a normal comparison
and illustrated how the prematurely born children normalized with time in height and weight.
Unique aspects of this study include the sample and design with prospective classification by
neonatal morbidity, SES stratification, longitudinal design with regular assessment intervals,
long duration of follow-up, and a very high compliance rate. Unlike many preterm follow-up
studies, this study sample was recruited specifically for research purposes, not health service
delivery, thus following research standards in its protocols. This is an important distinction
because little is known about potential differences in the quality of data collected in clinical
follow-up versus research settings (Lester & Miller-Loncar, 2000). Birth dates for the sample
are 1985–1989, a transition time for neonatal technologies such as surfactant and postnatal
Sullivan et al. Page 9
J Pediatr Health Care. Author manuscript; available in PMC 2010 February 12.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
steroids. Longitudinal preterm growth studies to school-age and early adolescence include
children born from the late 1970s and early 1980s, thus the present study extends our knowledge
of preterm growth in the context of late 1980s NICU technologies and its relationship to various
neonatal morbidities and birth weight. Survival rates for preterm infants have increased, but
the incidence of neonatal morbidity has remained constant; thus these findings are relevant for
current NICU survivors. We concur with Doyle (2000) that the outcomes of cohorts of the
immediate past reflect NICU practices of the time. Nevertheless, they are our best source for
how preterm infants born today and cared for with newer NICU technologies may progress in
growth at later ages.
Implications for Clinical Practice
Given the growing numbers of premature infants, more clinicians will be caring for children
who were born prematurely with various types of perinatal morbidity. Our results highlight
that the health history include details of the NICU course, neonatal diagnoses, and discharge
summary. Because many infants require multiple medical specialists, allied health therapists,
and participate in intervention programs, Kelly (2006) suggests that families keep a shadow
chart that serves to keep pediatric professionals updated.
Serial measures of height, weight, BMI, and head circumference are important in preterm infant
follow-up, not only to identify adequate growth, but to evaluate the trajectory for infants who
had particular neonatal morbidities. A clinical application of these findings would incorporate
how neonatal morbidities and birth weight inform weight and height fluctuations at different
ages. Helping parents anticipate rapid growth in the first 12 to 18 months followed by varying
rates of catch-up in the preschool and school-age years may reduce concerns about their child's
health. Adequate nutrition and feeding problems are common parental concerns, which can be
complicated by oral sensory, medical, and behavioral issues. An overlay to mark the timing of
intervention for these issues would further enlighten plotted growth trajectories. BMI was
appropriate for the majority of premature children in this sample. Using BMI to determine
overweight will be an important anticipatory strategy as the child reaches adolescence and
young adulthood. The six areas identified in the HEAT initiative (NAPNAP, 2006) are
evidence-based strategies to prevent the tendency of low birth weight infants to have adult
overweight and obesity.
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FIGURE 1.
Comparing Full Term Height z Scores with the Preterm Groups
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FIGURE 2.
Comparing Full Term Weight z Scores with the Preterm Groups
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